Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia — NEJM

Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia — NEJM

瀏覽:362
日期:2024-08-22
Original Article from The New England Journal of Medicine — Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia ... Results Serum sodium concentrations increased more in the tolvaptan group than in the placebo group during the...看更多